Dear Colleagues & Friends,

It is with a great pleasure that we welcome you to this IFMAD edition which after this pandemic year will be providing and even more comprehensive scientific and educational programme. After closely following the evolution of the pandemic, the Chairmen have considered the idea of having the Congress in an in-person conference and a virtual conference format.

This will allow people who, for a variety of reasons, will not be able to join to participate and benefit to what the the “fil rouge” of the 19th edition will focus on :

Treatment Resistant Depression, Augmentation strategies in MDD, Prevention of suicide, Inflammation and Cognition in Mood and Anxiety Disorders, ADHD in adults, COVID-19 lockdown effects on mental Health, Preventing Illness Progression in Bipolar Disorder, Personalised psychiatry: are we there yet?

It is accredited for continuing medical education. In a friendly atmosphere difficult clinical challenges are dissected, discussed and reformulated with high ranking experts to achieve the best evidence based path to treatment in depression, anxiety and bipolar disorder. To avoid bias, our educational program is completely independent from pharmaceutical support.

We look forward to seeing you all in Budapest or to meet you virtually, in order to keep building strong professional contacts an expanding international network, to welcoming new participants and meeting our old friends, and discussing together the most important issues in this area of medicine!

The IFMAD Chairmen